This post is from a low-reputation account and contains an unverified outbound link. Be cautious before clicking external links.
Hormonal therapy is a vital component in the treatment of hormone-receptor-positive breast cancer, effectively lowering the chances of recurrence and improving survival rates. However, its benefits often come with a trade-off, particularly concerning bone health. One primary way hormonal therapy affects bone health is by reducing estrogen levels.